Mohr et al. [15] also showed that infusion of MSCs could significantly improve the decrease of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activity caused by ischemia-reperfusion, which is beneficial to the improvement of acute renal failure caused by ischemia-reperfusion. The gene discussed is SOD1; the disease is acute kidney injury.